Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
IEEE/ACM Transactions on Computational Biology and Bioinformatics
|
July 12, 2018
EBWS: Essential Bioinformatics Web Services for Sequence Analyses
Dimitrios Kaloudas, Nikolet Pavlova, Robert Penchovsky
Methods in Molecular Biology (Clifton, N.J.)
|
June 22, 2024
Computational Design of Allosteric Ribozymes via Genetic Algorithms
Dimitrios Kaloudas, Nikolet Pavlova, Robert Penchovsky
Antibiotics (Basel, Switzerland)
|
November 24, 2023
Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development
Nikolet Pavlova, Martina Traykovska, Robert Penchovsky
International Journal of Biological Macromolecules
|
May 10, 2026
Computational selection of allosteric RNAs: A review
Dimitrios Kaloudas, Nikolet Pavlova, Robert Penchovsky
Molecules (Basel, Switzerland)
|
August 28, 2025
Targeting Bacterial Adenylate Kinase mRNA with a Chimeric Antisense Oligonucleotide for Rational Antibacterial Drug Development
Lozena A Otcheva, Martina Traykovska, Robert Penchovsky
ACS Synthetic Biology
|
November 4, 2021
Targeting glmS Ribozyme with Chimeric Antisense Oligonucleotides for Antibacterial Drug Development
Martina Traykovska, Katya B Popova, Robert Penchovsky
RNA Biology
|
November 23, 2006
Development and application of a high-throughput assay for glmS riboswitch activators
Kenneth Blount, Izabela Puskarz, Robert Penchovsky, et al.
ACS Applied Bio Materials
|
September 28, 2022
Targeting TPP Riboswitches Using Chimeric Antisense Oligonucleotide Technology for Antibacterial Drug Development
Martina Traykovska, Lozena A Otcheva, Robert Penchovsky
Antibiotics (Basel, Switzerland)
|
March 27, 2024
Antisense and Functional Nucleic Acids in Rational Drug Development
Robert Penchovsky, Antoniya V Georgieva, Vanya Dyakova, et al.
ACS Infectious Diseases
|
December 18, 2025
Rational Design of Chimeric Antisense Oligonucleotides that Target FMN Riboswitch mRNAs and Inhibit the Growth of Methicillin-Resistant <i>Staphylococcus aureus</i>
Vanya N Dyakova, Martina Traykovska, Nikolet Pavlova, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
IEEE/ACM Transactions on Computational Biology and Bioinformatics
|
July 12, 2018
EBWS: Essential Bioinformatics Web Services for Sequence Analyses
Dimitrios Kaloudas, Nikolet Pavlova, Robert Penchovsky
Methods in Molecular Biology (Clifton, N.J.)
|
June 22, 2024
Computational Design of Allosteric Ribozymes via Genetic Algorithms
Dimitrios Kaloudas, Nikolet Pavlova, Robert Penchovsky
Antibiotics (Basel, Switzerland)
|
November 24, 2023
Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development
Nikolet Pavlova, Martina Traykovska, Robert Penchovsky
International Journal of Biological Macromolecules
|
May 10, 2026
Computational selection of allosteric RNAs: A review
Dimitrios Kaloudas, Nikolet Pavlova, Robert Penchovsky
Molecules (Basel, Switzerland)
|
August 28, 2025
Targeting Bacterial Adenylate Kinase mRNA with a Chimeric Antisense Oligonucleotide for Rational Antibacterial Drug Development
Lozena A Otcheva, Martina Traykovska, Robert Penchovsky
ACS Synthetic Biology
|
November 4, 2021
Targeting glmS Ribozyme with Chimeric Antisense Oligonucleotides for Antibacterial Drug Development
Martina Traykovska, Katya B Popova, Robert Penchovsky
RNA Biology
|
November 23, 2006
Development and application of a high-throughput assay for glmS riboswitch activators
Kenneth Blount, Izabela Puskarz, Robert Penchovsky, et al.
ACS Applied Bio Materials
|
September 28, 2022
Targeting TPP Riboswitches Using Chimeric Antisense Oligonucleotide Technology for Antibacterial Drug Development
Martina Traykovska, Lozena A Otcheva, Robert Penchovsky
Antibiotics (Basel, Switzerland)
|
March 27, 2024
Antisense and Functional Nucleic Acids in Rational Drug Development
Robert Penchovsky, Antoniya V Georgieva, Vanya Dyakova, et al.
ACS Infectious Diseases
|
December 18, 2025
Rational Design of Chimeric Antisense Oligonucleotides that Target FMN Riboswitch mRNAs and Inhibit the Growth of Methicillin-Resistant <i>Staphylococcus aureus</i>
Vanya N Dyakova, Martina Traykovska, Nikolet Pavlova, et al.
Page
of 4